Why the study?
Anticancer treatments are often accompanied by significant side effects, with AF being the most frequently encountered drug-associated arrhythmia, and management in cancer patients is currently conducted largely on pragmatic assumptions.
What are the mechanisms and risk factors for atrial fibrillation induced by anticancer drugs in cancer patients?
What are the mechanisms and risk factors for atrial fibrillation induced by anticancer drugs in cancer patients?
This review highlights that anticancer drugs can induce atrial fibrillation, often synergistically with preexisting risk factors, necessitating careful management in cardio-oncology.
No takes yet. Share an insight, caveat, or question.
AF monitoring warranted during antineoplastic therapy; leaves open dedicated prevention trials in high-risk oncology patients.
Alexander Burashnikov (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: